$1.09
-0.05-4.39%
Last update: Oct 30, 7:44 PM
Vivani Medical Inc (VANI) Stock Price, Quote, News & History
VANINASDAQ
Vivani reported Phase 1 success for its exenatide implant and shared preclinical semaglutide data showing 231-day weight loss from a single dose.
You can purchase shares of Vivani Medical (NASDAQ:VANI) through any online brokerage.
Other companies in Vivani Medical’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
Vivani Medical has a consensus price target of $3.75.
The stock price for Vivani Medical (NASDAQ: VANI) is $1.07 last updated October 30, 2026 at 7:44 PM EDT.
There are no upcoming dividends for Vivani Medical.
Vivani Medical does not have any upcoming earnings scheduled.
There is no upcoming split for Vivani Medical.
Vivani Medical is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting,...
